NOVOTECH INVESTMENTS
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2016-11-29 | Hexis Lab | Novotech Investments investment in Seed Round - Hexis Lab | 200 K GBP |
More informations about "Novotech Investments"
Novotech Welcomes New Investment from GIC, Temasek, and โฆ
Mar 31, 2025 Since our investment in 2017, Novotech has grown from a 300-person organization operating predominantly in Australia and New Zealand and some parts of Asia, to now a 3,000-person organization with a global presence. TPG has a long history of partnering with management teams to deliver long-term value creation, and by re-investing through TPG ...See details»
Investment firms secure large stakes in CRO Novotech
Apr 2, 2025 Two investment firms have acquired large stakes in global CRO Novotech, the Singapore-based company announced March 30.. GIC and Temasek have invested in Novotech with the goal of providing funds ...See details»
Novotech - Funding, Financials, Valuation & Investors - Crunchbase
Jan 9, 2023 Novotech has made 3 investments. Their most recent investment was on Jan 24, 2022, when Prospection raised a new funding round. Novotech has acquired 4 organizations. Their most recent acquisition was CBR International on Jan 9, 2023.See details»
Singapore-headquartered biotech specialist CRO Novotechโs stake ...
Apr 8, 2025 Novotech, a full-service biotech specialist clinical research organization (CRO) with its headquarters in Singapore, announced that GIC and Temasek af ... โSince our investment in 2017, Novotech has grown from a 300-person organization operating predominantly in Australia and New Zealand and some parts of Asia, to now a 3,000-person ...See details»
Novotech Secures Major Investment from GIC, Temasek, and TPG โฆ
Mar 31, 2025 CEO John Moller said the investment will bolster Novotechโs position as a global CRO leader, particularly as clinical trial demand in the Asia-Pacific region is projected to grow by 15% annually. โNovotech is already on its way to being a major global player in the CRO space, with 3,000 employees and experience in more than 6,000 clinical projects,โ Moller said.See details»
Early-Stage Biotech Investments Were Down 40% in 2023: โฆ
Jan 9, 2024 Boston, USA - Novotech, the leading Asia. Boston, USA - Novotech, the leading Asia ... investments in early-stage biotech companies declined by 40% in 2023 compared to 2022, marking an unprecedented 55% drop from two years prior,โ the whitepaper found. ... Novotech is a globally recognized full-service clinical research organization (CRO) and ...See details»
Novotech Receives Investment From GIC, Temasek, and TPG
Mar 31, 2025 Novotech, a Sydney, Australia-based biotech specialist clinical research organization (CRO), received an investment from GIC, Teasek and TPG.. The amount of the deal was not disclosed. The company ...See details»
2 investment firms secure large stakes in Novotech
Apr 2, 2025 The investments value Novotech at more than $1.9 billion, according to a March 30 report from Bloomberg. โNovotech is already on its way to be a major global player in the CRO space, with 3,000 employees and experience across more than 6,000 clinical projects,โ Novotech CEO John Moller said in the release. โWe are excited by the new ...See details»
GIC, Temasek, TPG back Singapore biotech Novotech | The Asset
Mar 31, 2025 New investment to allow firm to pursue growth, transformative M&A opportunities ... Singapore-headquartered Novotech, a biotech specialist clinical research organization ( CRO ), has signed binding agreements with affiliates of Singapore sovereign funds GIC and Temasek to acquire a significant stake in the company, with the additional capital ...See details»
Novotech - Crunchbase Company Profile & Funding
Novotech closed its last funding round on Mar 31, 2025 from a Private Equity round. Who are Novotech 's competitors? Alternatives and possible competitors to Novotech may include Intarcia Therapeutics , Proclara Biosciences , and โฆSee details»
Novotech - 2025 Funding Rounds & List of Investors - Tracxn
Apr 28, 2025 TPG, located in Fort Worth (United States), made their first investment in Novotech on Mar 31, 2025 in its Seed round.; Temasek, located in Singapore (Singapore), made their first investment in Novotech on Mar 31, 2025 in its Seed round.; Sequoia Capital, located in Menlo Park (United States), made their first investment in Novotech on Feb 02, 2021 in its PE round.See details»
Novotech - 2025 Company Profile, Funding & Competitors - Tracxn
Apr 28, 2025 Novotech has raised a total funding of $255M over 5 rounds. Its first funding round was on Apr 30, 2013. Its latest funding round was a Seed round on Mar 31, 2025 for an undisclosed amount. 3 investors participated in its latest round, which includes TPG, Temasek, GIC and Sequoia Capital.See details»
Novotech Investments - Crunchbase Investor Profile & Investments
Hexis Lab raised £200,000 / Seed from Northstar Ventures and Novotech Investments. Discover more funding rounds . Details. Edit Details Section. Headquarters Regions Europe, Middle East, and Africa (EMEA) Operating Status Active; Company Type For โฆSee details»
Novotech Welcomes New Investment From GIC, Temasek, and โฆ
Mar 31, 2025 Since our investment in 2017, Novotech has grown from a 300-person organization operating predominantly in Australia and New Zealand and some parts of Asia, to now a 3,000-person organization with ...See details»
Novotech Company Overview, Contact Details & Competitors
Novotech. Biotechnology Research New South Wales, Australia 1001-5000 Employees. Novotech is a globally recognized full-service clinical research organization (CRO) and scientific advisory company that provides biotech and small- to mid-sized pharma companies an accelerated path to market since 1997.See details»
Novotech IM prepped ahead of secondary sale; FY25 ests revealed
Aug 13, 2024 Novotech is one of TPGโs larger investments in Australia and Asia, held since 2017. The company was founded in 1996 in Sydney and sold a 50 per cent stake to Clark Perkinsโ Mercury Capital in ...See details»
Novotech Welcomes New Investment From GIC, Temasek, and โฆ
Mar 31, 2025 SYDNEY--BUSINESS WIRE-- Novotech, a globally recognized full-service biotech specialist clinical research organization (CRO), announced today that affiliates of GIC and Temasek have signed binding agreements to acquire a significant stake in the company, with the additional capital earmarked to accelerate its global growth. Existing investor TPG will also โฆSee details»
Novotech Analysis Highlights Rising Clinical Development Efforts โฆ
1 day ago SYDNEY, May 08, 2025--Novotech, a leading global clinical research organization (CRO) and scientific advisory partner, has published a report analyzing recent trends in obesity-related clinical ...See details»
Novotech Welcomes New Investment From GIC, Temasek, and โฆ
Mar 31, 2025 Novotech, a globally recognized full-service biotech specialist clinical research organization (CRO), announced today that affiliates of GIC and Temasek have signed binding agreements to acquire a ...See details»
Exclusive: Crypto VC giant Paradigm makes $50 million bet on ...
Apr 25, 2025 Exclusive: Crypto VC giant Paradigm makes $50 million bet on decentralized AI startup Nous Research at $1 billion token valuationSee details»